Header links
Intranet
Dona
image/svg+xml Mapa
Contacte

Publicacions

Cercador de Publicacions

La producció científica dels nostres investigadors i investigadores és molt elevada. L'any 2022 es van publicar 1.629 articles a revistes científiques amb un factor d'impacte global que va superar els 15.000 punts.

First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study.

PMID: 34804931
Revista: Frontiers in Oncology
Any: 2021
Referència: Front Oncol. 2021 Nov 4;11:744112. doi: 10.3389/fonc.2021.744112. eCollection 2021.
Factor d'impacte: 6.244
Tipus de publicació: Article en revista internacional
Autors: Burgues, Octavio, Pernas, Sonia, Villagrasa, Patricia, Vivancos, Ana, Scaltriti, Maurizio, Rodon, Jordi, Pare, Laia, Duenas, Marta, Vidal, Maria, Cejalvo, Juan Miguel et al.
DOI: 10.3389/fonc.2021.744112

First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study.

PMID: 34804931
Revista: Frontiers in Oncology
Any: 2021
Referència: Front Oncol. 2021 Nov 4;11:744112. doi: 10.3389/fonc.2021.744112. eCollection 2021.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Burgues, Octavio; Canes, Jordi; Cejalvo, Juan Miguel; Ciruelos, Eva; Dorca, Joan; Duenas, Marta; Llommbard-Cussac, Antonio; Montano, Alvaro; Nuciforo, Paolo; Oliveira, Mafalda et al.
DOI: 10.3389/fonc.2021.744112

First-In-Human Phase I Study of a Next-Generation, Oral, TGFbeta Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer.

PMID: 34548321
Revista: CLINICAL CANCER RESEARCH
Any: 2021
Referència: Clin Cancer Res. 2021 Dec 15;27(24):6666-6676. doi: 10.1158/1078-0432.CCR-21-1504. Epub 2021 Sep 21.
Factor d'impacte: 12.531
Tipus de publicació: Article en revista internacional
Autors: Simonelli, Matteo, Cosman, Rasha, van der Westhuizen, Andre, Atkinson, Victoria, Carpentier, Antoine F, Lohr, Mario, Redman, Rebecca, Mason, Warren, Cervantes, Andres, Le Rhun, Emilie et al.
DOI: 10.1158/1078-0432.CCR-21-1504

First-In-Human Phase I Study of a Next-Generation, Oral, TGFbeta Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer.

PMID: 34548321
Revista: CLINICAL CANCER RESEARCH
Any: 2021
Referència: Clin Cancer Res. 2021 Dec 15;27(24):6666-6676. doi: 10.1158/1078-0432.CCR-21-1504. Epub 2021 Sep 21.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Atkinson, Victoria; Avsar, Emin; Baldini, Capucine; Callies, Sophie; Carpentier, Antoine F; Cervantes, Andres; Cosman, Rasha; Estrem, Shawn T; Gandhi, Leena; Kondo, Shunsuke et al.
DOI: 10.1158/1078-0432.CCR-21-1504

First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors.

PMID: 33301375
Revista: JOURNAL OF CLINICAL ONCOLOGY
Any: 2021
Referència: J Clin Oncol. 2021 Jan 10;39(2):145-154. doi: 10.1200/JCO.20.00596. Epub 2020 Dec 10.
Factor d'impacte: 44.544
Tipus de publicació: Article en revista internacional
Autors: Stumpp, Michael T, Harstrick, Andreas, Azaro, Analia, Fischer, Stefanie, Omlin, Aurelius, Leupin, Nicolas, Dawson, Keith M, Fiedler, Ulrike, Zitt, Christof, Baird, Richard D et al.
DOI: 10.1200/JCO.20.00596

First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors.

PMID: 33301375
Revista: JOURNAL OF CLINICAL ONCOLOGY
Any: 2021
Referència: J Clin Oncol. 2021 Jan 10;39(2):145-154. doi: 10.1200/JCO.20.00596. Epub 2020 Dec 10.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Azaro, Analia; Baird, Richard D; Dawson, Keith M; Fiedler, Ulrike; Fischer, Stefanie; Harris, Adrian; Harstrick, Andreas; Leupin, Nicolas; Linossi, Constanza; Lord, Simon et al.
DOI: 10.1200/JCO.20.00596

First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas.

PMID: 34389618
Revista: Journal for ImmunoTherapy of Cancer
Any: 2021
Referència: J Immunother Cancer. 2021 Aug;9(8). pii: jitc-2021-002863. doi: 10.1136/jitc-2021-002863.
Factor d'impacte: 13.751
Tipus de publicació: Article en revista internacional
Autors: Piha-Paul, Sarina A, Geva, Ravit, Tan, Tira J, Lim, Darren Wt, Hierro, Cinta, Doi, Toshikiko, Rahma, Osama, Lesokhin, Alexander, Luke, Jason John, Otero, Javier et al.
DOI: 10.1136/jitc-2021-002863

First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas.

PMID: 34389618
Revista: Journal for ImmunoTherapy of Cancer
Any: 2021
Referència: J Immunother Cancer. 2021 Aug;9(8). pii: jitc-2021-002863. doi: 10.1136/jitc-2021-002863.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Bedard, Philippe L; Chen, Xinhui; Doi, Toshikiko; Geva, Ravit; Hierro, Cinta; Lesokhin, Alexander; Lim, Darren Wt; Luke, Jason John; Mataraza, Jennifer; Nardi, Lisa et al.
DOI: 10.1136/jitc-2021-002863

First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study.

PMID: 33957442
Revista: EUROPEAN JOURNAL OF CANCER
Any: 2021
Referència: Eur J Cancer. 2021 Jul;151:14-24. doi: 10.1016/j.ejca.2021.03.028. Epub 2021 May 4.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Bekaii-Saab, Tanios; Belanger, Bruce; Boland, Patrick M; Dayyani, Farshid; Dean, Andrew; Macarulla, Teresa; Maxwell, Fiona; Mody, Kabir; Moore, Yan; Thiagalingam, Arunthathi et al.
DOI: 10.1016/j.ejca.2021.03.028

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial.

PMID: 33476593
Revista: LANCET ONCOLOGY
Any: 2021
Referència: Lancet Oncol. 2021 Feb;22(2):198-211. doi: 10.1016/S1470-2045(20)30641-0. Epub 2021 Jan 18.
Factor d'impacte: 41.316
Tipus de publicació: Article en revista internacional
Autors: Oukessou, Abderrahim, Yan, Jinchun, Reck, Martin, Agrawal, Shruti, Meadows-Shropshire, Stephanie, Carbone, David P, John, Thomas, Paz-Ares, Luis, Ciuleanu, Tudor-Eliade, Cobo, Manuel et al.
DOI: 10.1016/S1470-2045(20)30641-0

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial.

PMID: 33476593
Revista: LANCET ONCOLOGY
Any: 2021
Referència: Lancet Oncol. 2021 Feb;22(2):198-211. doi: 10.1016/S1470-2045(20)30641-0. Epub 2021 Jan 18.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Agrawal, Shruti; Alexandru, Aurelia; Bennouna, Jaafar; Carbone, David P; Ciuleanu, Tudor-Eliade; Cobo, Manuel; De Marchi, Pedro; Felip, Enriqueta; John, Thomas; Juan-Vidal, Oscar et al.
DOI: 10.1016/S1470-2045(20)30641-0

First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update.

PMID: 34607285
Revista: ESMO Open
Any: 2021
Referència: ESMO Open. 2021 Oct;6(5):100273. doi: 10.1016/j.esmoop.2021.100273. Epub 2021 Oct 1.
Factor d'impacte: 6.54
Tipus de publicació: Article en revista internacional
Autors: Tran, P, John, T, Zhang, X, Marimuthu, S, Memaj, A, Carbone, D P, Reck, M, Ciuleanu, T-E, Cobo, M, Schenker, M et al.
DOI: 10.1016/j.esmoop.2021.100273

First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update.

PMID: 34607285
Revista: ESMO Open
Any: 2021
Referència: ESMO Open. 2021 Oct;6(5):100273. doi: 10.1016/j.esmoop.2021.100273. Epub 2021 Oct 1.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Alexandru, A; Bennouna, J; Carbone, D P; Ciuleanu, T-E; Cobo, M; De Marchi, P; Felip, E; John, T; Juan-Vidal, O; Lingua, A et al.
DOI: 10.1016/j.esmoop.2021.100273

First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811.

PMID: 33167735
Revista: Future Oncology
Any: 2021
Referència: Future Oncol. 2021 Feb;17(5):491-501. doi: 10.2217/fon-2020-0737. Epub 2020 Nov 10.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Alsina, Maria; Bang, Yung-Jue; Bhagia, Pooja; Cao, Zhu Alexander; Chung, Hyun Cheol; Cutsem, Eric van; Janjigian, Yelena Y; Lu, Jia; Qin, Shu-Kui; S Fuchs, Charles et al.
DOI: 10.2217/fon-2020-0737

Fit-for-Discharge Criteria after Esophagectomy: An International Expert Delphi Consensus.

PMID: 32960264
Revista: DISEASES OF THE ESOPHAGUS
Any: 2021
Referència: Dis Esophagus. 2021 Jun 14;34(6). pii: 5909885. doi: 10.1093/dote/doaa101.
Factor d'impacte: 3.429
Tipus de publicació: Article en revista internacional
Autors: van Veer, H, Low, D E, Luyer, M, Markar, S R, Monig, S P, Moorthy, K, Morse, C R, Muller-Stich, B P, Nafteux, P, Nieponice, A et al.
DOI: 10.1093/dote/doaa101

Fit-for-Discharge Criteria after Esophagectomy: An International Expert Delphi Consensus.

PMID: 32960264
Revista: DISEASES OF THE ESOPHAGUS
Any: 2021
Referència: Dis Esophagus. 2021 Jun 14;34(6). pii: 5909885. doi: 10.1093/dote/doaa101.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Bonavina, L; Brown, W; Castro, S; Cheong, E; Darling, G E; Egberts, J; Ferri, L; Gisbertz, S S; Gockel, I; Grimminger, P P et al.
DOI: 10.1093/dote/doaa101

Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.

PMID: 33449799
Revista: JOURNAL OF CLINICAL ONCOLOGY
Any: 2021
Referència: J Clin Oncol. 2021 Mar 1;39(7):723-733. doi: 10.1200/JCO.20.01605. Epub 2021 Jan 15.
Factor d'impacte: 44.544
Tipus de publicació: Article en revista internacional
Autors: Burgio, Marco Angelo, Borghaei, Hossein, Gettinger, Scott, Vokes, Everett E, Chow, Laura Q M, Marimuthu, Sathiya, Arrieta, Oscar, Frontera, Osvaldo Aren, Chiari, Rita, Butts, Charles et al.
DOI: 10.1200/JCO.20.01605

Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.

PMID: 33449799
Revista: JOURNAL OF CLINICAL ONCOLOGY
Any: 2021
Referència: J Clin Oncol. 2021 Mar 1;39(7):723-733. doi: 10.1200/JCO.20.01605. Epub 2021 Jan 15.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Antonia, Scott; Arrieta, Oscar; Barlesi, Fabrice; Borghaei, Hossein; Brahmer, Julie; Burgio, Marco Angelo; Butts, Charles; Chiari, Rita; Chow, Laura Q M; Coudert, Bruno et al.
DOI: 10.1200/JCO.20.01605

Five-year prognosis after TIA or minor ischemic stroke in Asian and non-Asian countries.

PMID: 33046613
Revista: NEUROLOGY
Any: 2021
Referència: Neurology. 2021 Jan 5;96(1):e54-e66. doi: 10.1212/WNL.0000000000010995. Epub 2020 Oct 12.
Factor d'impacte: 9.91
Tipus de publicació: Article en revista internacional
Autors: Caplan, Louis R, Hoshino, Takao, Uchiyama, Shinichiro, Wong, Lawrence K S, Kitagawa, Kazuo, Charles, Hugo, Labreuche, Julien, Lavallee, Philippa C, Albers, Gregory W, Hennerici, Michael G et al.
DOI: 10.1212/WNL.0000000000010995

Five-year prognosis after TIA or minor ischemic stroke in Asian and non-Asian countries.

PMID: 33046613
Revista: NEUROLOGY
Any: 2021
Referència: Neurology. 2021 Jan 5;96(1):e54-e66. doi: 10.1212/WNL.0000000000010995. Epub 2020 Oct 12.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Albers, Gregory W; Amarenco, Pierre; Caplan, Louis R; Charles, Hugo; Donnan, Geoffrey A; Ferro, Jose M; Gabriel Steg, P; Hennerici, Michael G; Hoshino, Takao; Kitagawa, Kazuo et al.
DOI: 10.1212/WNL.0000000000010995

Fluid balance and outcome in critically ill patients with traumatic brain injury (CENTER-TBI and OzENTER-TBI): a prospective, multicentre, comparative effectiveness study.

PMID: 34302787
Revista: LANCET NEUROLOGY
Any: 2021
Referència: Lancet Neurol. 2021 Aug;20(8):627-638. doi: 10.1016/S1474-4422(21)00162-9.
Factor d'impacte: 44.182
Tipus de publicació: Article en revista internacional
Autors: Frisvold, Shirin, Wiegers, Eveline Janine Anna, Lingsma, Hester Floor, Huijben, Jilske Antonia, Cooper, David James, Citerio, Giuseppe, Furmanov, Alex, Verheyden, Jan, Misset, Benoit, Ledoux, Didier et al.
DOI: 10.1016/S1474-4422(21)00162-9

Fluid balance and outcome in critically ill patients with traumatic brain injury (CENTER-TBI and OzENTER-TBI): a prospective, multicentre, comparative effectiveness study.

PMID: 34302787
Revista: LANCET NEUROLOGY
Any: 2021
Referència: Lancet Neurol. 2021 Aug;20(8):627-638. doi: 10.1016/S1474-4422(21)00162-9.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Ackerlund, Cecilia; Adams, Hadie; Amrein, Krisztina; Andelic, Nada; Andreassen, Lasse; Anke, Audny; Antoni, Anna; Audibert, Gerard; Azouvi, Philippe; Azzolini, Maria Luisa et al.
DOI: 10.1016/S1474-4422(21)00162-9

Fluorescence-based bowel anastomosis perfusion evaluation: results from the IHU-IRCAD-EAES EURO-FIGS registry.

PMID: 33492508
Revista: SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
Any: 2021
Referència: Surg Endosc. 2021 Dec;35(12):7142-7153. doi: 10.1007/s00464-020-08234-8. Epub 2021 Jan 25.
Factor d'impacte: 4.584
Tipus de publicació: Article en revista internacional
Autors: de Manzini, Nicolo, Spota, Andrea, Al-Taher, Mahdi, Felli, Eric, Morales Conde, Salvador, Dal Dosso, Ivano, Moretto, Gianluigi, Spinoglio, Giuseppe, Baiocchi, Gianluca, Vilallonga, Ramon et al.
DOI: 10.1007/s00464-020-08234-8

Fluorescence-based bowel anastomosis perfusion evaluation: results from the IHU-IRCAD-EAES EURO-FIGS registry.

PMID: 33492508
Revista: SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
Any: 2021
Referència: Surg Endosc. 2021 Dec;35(12):7142-7153. doi: 10.1007/s00464-020-08234-8. Epub 2021 Jan 25.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Al-Taher, Mahdi; Anania, Gabriele; Baiocchi, Gianluca; Balla, Andrea; Bertani, Emilio; Bianchi, Giorgio; Boni, Luigi; Calabro, Marcello; Carus, Thomas; Casali, Lorenzo et al.
DOI: 10.1007/s00464-020-08234-8